{"product_id":"early-diagnosis-of-alzheimers-disease-clinical-guide","title":"Early Diagnosis of Alzheimers Disease - Clinical Guide","description":"\u003cp\u003eIn this review of Early Diagnosis of Alzheimers Disease, the authors Leonard F. M. Scinto and Kirk R. Daffner assemble a focused academic resource aimed at clinicians and researchers seeking rigor on early markers of Alzheimer disease. The book's single biggest reason to buy is its systematic survey of contemporary diagnostic approaches, combining neuroimaging, neuropsychological testing, genetic markers, and biological assays into a cohesive reference. This review finds it most valuable as a clinical reference rather than a general-audience primer, and it consistently emphasizes evidence and methodology over anecdote.\u003c\/p\u003e\n\u003ch2\u003eKey Features\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eComprehensive scope:\u003c\/strong\u003e The book surveys current research across multiple diagnostic domains so clinicians can compare approaches in one volume.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eNeuroimaging focus:\u003c\/strong\u003e Contributors elucidate structural and functional brain changes, making the material useful for interpreting imaging findings.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eNeuropsychological detail:\u003c\/strong\u003e Characteristic patterns of cognitive decline are documented with sensitive testing paradigms that guide early assessment.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBiomarker coverage:\u003c\/strong\u003e Genetic markers and biological assays are reviewed to help integrate laboratory data into diagnostic reasoning.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eExpert contributors:\u003c\/strong\u003e Authored and edited by established clinicians, the text synthesizes critical viewpoints rather than offering unchecked optimism.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eWho It's For\u003c\/h2\u003e\n\u003cp\u003eThis book is best for neurologists, geriatricians, neuropsychologists, and clinical researchers who need a concentrated review of early diagnostic markers for Alzheimer disease. It works well as a reference on the shelf for case conferences, protocol development, or preparing grant proposals where an evidence-based synthesis is required.\u003c\/p\u003e\n\u003cp\u003eClinicians seeking a quick consumer guide, caregivers, or readers without a medical background should look elsewhere, as the material assumes familiarity with clinical terminology and diagnostic testing methodologies.\u003c\/p\u003e\n\u003ch2\u003ePros \u0026amp; Cons\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003ePros\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eBrings together imaging, cognitive testing, genetics, and assays in a single reference for integrated diagnostics.\u003c\/li\u003e\n\u003cli\u003eEmphasizes methodological rigor and critical appraisal from authoritative contributors.\u003c\/li\u003e\n\u003cli\u003eUseful for clinicians designing assessment protocols or interpreting complex diagnostic data.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eCons\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eNot written for lay readers; the clinical detail and technical language limit general accessibility.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eSpecifications\u003c\/h2\u003e\n\u003ctable\u003e\n\u003ctr\u003e\n\u003ctd\u003eTitle\u003c\/td\u003e\n\u003ctd\u003eEarly Diagnosis of Alzheimers Disease\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSeries\u003c\/td\u003e\n\u003ctd\u003eCurrent Clinical Neurology\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eEditors\/Authors\u003c\/td\u003e\n\u003ctd\u003eLeonard F. M. Scinto; Kirk R. Daffner\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSubject focus\u003c\/td\u003e\n\u003ctd\u003eEarly diagnostic markers for Alzheimer disease\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCoverage areas\u003c\/td\u003e\n\u003ctd\u003eNeuroimaging, neuropsychological tests, genetic markers, biological assays\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAudience\u003c\/td\u003e\n\u003ctd\u003eClinicians, researchers, neuropsychologists\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\n\u003ch2\u003eOur Verdict\u003c\/h2\u003e\n\u003cp\u003eEarly Diagnosis of Alzheimers Disease is a rigorous, well-organized clinical reference that consolidates current diagnostic research across modalities. Clinicians and researchers will find it good value for its focused synthesis and critical perspective, while those needing a lay introduction should consider a more accessible overview instead.\u003c\/p\u003e\n\u003ch2\u003eFrequently Asked Questions\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eDoes this book cover neuroimaging methods?\u003c\/strong\u003e\u003cbr\u003eThe book includes detailed discussion of structural and functional neuroimaging and how observed brain changes relate to early diagnosis.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eIs the text suitable for nonmedical readers?\u003c\/strong\u003e\u003cbr\u003eNo, the content is aimed at clinicians and researchers and uses technical terminology and methodology.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDoes it include genetic and biomarker information?\u003c\/strong\u003e\u003cbr\u003eYes, contributors review various genetic markers and biological assays relevant to early detection of Alzheimer disease.\u003c\/p\u003e","brand":"Leonard F. M. Scinto, Kirk R. Daffner","offers":[{"title":"Default Title","offer_id":48610248556763,"sku":"1468496018","price":119.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0724\/1043\/1707\/files\/61kcbwrXh2L._SL1179.jpg?v=1778576593","url":"https:\/\/gearmusthave.com\/products\/early-diagnosis-of-alzheimers-disease-clinical-guide","provider":"GearMustHave","version":"1.0","type":"link"}